Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2003 Dec;78(5):439-42.
doi: 10.1007/BF02983817.

MLL/AF-1p fusion in therapy-related early pre-B acute lymphoblastic leukemia with t(1;11)(p32;q23) translocation developing in the relapse phase of acute promyelocytic leukemia

Affiliations
Case Reports

MLL/AF-1p fusion in therapy-related early pre-B acute lymphoblastic leukemia with t(1;11)(p32;q23) translocation developing in the relapse phase of acute promyelocytic leukemia

Takayuki Tsujioka et al. Int J Hematol. 2003 Dec.

Abstract

We report the development of therapy-related early pre-B acute lymphoblastic leukemia in a patient administered a topoisomerase II inhibitor, etoposide, a consolidation therapy agent for acute promyelocytic leukemia. Our case is of interest because of simultaneous relapse of the original leukemia and onset of therapy-related leukemia and relatively rare t(1;11)(p32;q23) translocation with confirmed MLL/AF-1p fusion. This case suggests that careful monitoring for MLL gene rearrangements is necessary after administration of topoisomerase II inhibitors.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Leukemia. 2002 Oct;16(10):1940-58 - PubMed
    1. Science. 1999 Jul 9;285(5425):215-20 - PubMed
    1. Leukemia. 2003 May;17(5):876-82 - PubMed
    1. Cancer Surv. 1996;28:225-45 - PubMed
    1. Semin Hematol. 2002 Apr;39(2 Suppl 1):8-13 - PubMed

Publication types

MeSH terms

LinkOut - more resources